Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
09/2014
09/18/2014WO2014140073A1 Process for making benzoxazepin compounds
09/18/2014WO2014139324A1 Tetracyclic bromodomain inhibitors
09/18/2014US20140275523 Process for making benzoxazepin compounds
09/18/2014US20140275092 Pyrazolo compounds and uses thereof
09/18/2014US20140275059 Dna-pk inhibitors
09/18/2014US20140275056 P2x7 modulators
09/18/2014US20140275055 Protein Kinase C Inhibitors and Uses Thereof
09/18/2014US20140275030 Tricyclic heterocycles as bet protein inhibitors
09/18/2014US20140275025 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014US20140275024 Dna-pk inhibitors
09/18/2014US20140275006 Azole derivative
09/18/2014US20140274926 Compounds and compositions for the treatment of parasitic diseases
09/17/2014EP2778156A1 Phenoxypyridinylamide derivatives and their use in the treatment of PDE4 mediated disease states
09/17/2014EP2776427A1 Modulators of atp-binding cassette transporters
09/16/2014US8835452 Polymorphic forms α, β and γ of rifaximin
09/16/2014US8835440 Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPD
09/16/2014US8835430 2,4-pyrimidinediamine compounds and their uses
09/16/2014US8835429 Pyrimidine compounds, their use as mTOR kinase and Pl3 kinase inhibitors, and their syntheses
09/16/2014US8835422 Substituted imidazoheterocycle derivatives
09/12/2014WO2014138239A1 Compounds for the treatment of hepatitis c
09/12/2014WO2014135414A1 Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
09/11/2014US20140256948 3-cyano-quinoline derivatives with antiproliferative activity
09/11/2014US20140256937 Polycyclic pyridone derivative having integrase inhibitory activity
09/11/2014US20140256714 Macrocyclic quinazole derivatives and their use as mtki
09/11/2014US20140256679 Chemical compounds
09/10/2014EP2774928A1 Polycyclic pyridone derivative having integrase-inhibiting activity
09/10/2014EP2773632A1 8-fluorophthalazin-1 (2h) - one compounds as inhibitors of btk activity
09/10/2014EP2773631A1 Pesticidal compounds
09/09/2014US8829023 Process for obtaining compounds derived from tetrahydro-β-carboline
09/09/2014US8828996 Morpholine-spirocyclic piperidine amides as modulators of ion channels
09/09/2014US8828989 Oxy-cyclohexyl-4H,6H-5-oxa-2,3,10b-triaza-benzo[E]azulenes as V1A antagonists
09/09/2014US8828983 Macrocycles as factor XIa inhibitors
09/09/2014CA2789415C Macrolides
09/04/2014WO2014134341A1 Perfluorinated 5,6-dihydro-4h-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
09/04/2014US20140249170 Heterocyclic compounds as inhibitors of fatty acid biosysnthesis for bacterial infections
09/04/2014US20140249143 Compounds And Methods For Enhancing Innate Immune Responses
09/04/2014US20140249133 Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases
09/04/2014US20140249129 Substituted Bicyclic Dihydropyrimidinones And Their Use As Inhibitors Of Neutrophil Elastase Activity
09/03/2014EP2772485A1 Bicyclic compound
09/03/2014EP2771346A1 Isoxazolopyridine orexin receptor antagonists
09/03/2014EP2771345A1 Fused bicyclic oxazolidinone cetp inhibitor
09/03/2014EP2771337A1 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
09/02/2014US8822689 Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
09/02/2014US8822688 Imidazo[1,2-a]pyridine derivative
09/02/2014US8822685 2,4-pyrimidinediamine compounds and their uses
09/02/2014US8822678 Method for synthesizing temsirolimus
09/02/2014US8822458 Substituted oxazolidinones and their use in the field of blood coagulation
09/02/2014US8822193 Isolated bacterial strain of the genus Burkholderia and pesticidal metabolites therefrom
08/2014
08/28/2014WO2014128486A1 Pyrimidine compounds useful in the treatment of diseases mediated by ikke and/or tbk1 mechanisms
08/28/2014WO2014081821A3 Small Molecule Bicyclic and Tricyclic CFTR Correctors
08/28/2014US20140243521 Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates
08/28/2014US20140243519 Methods and intermediates for preparing macrolactams
08/28/2014US20140243316 Tetrahydroimidazo(1,5-D)[1,4]Oxazepine Derivative
08/28/2014US20140243310 Bicyclic compound
08/28/2014US20140243302 Bridged bicyclic compounds for the treatment of bacterial infections
08/28/2014US20140243288 Fused ring-containing oxazolidinones antibiotics
08/28/2014US20140243284 Biologically active macrolides, compositions, and uses thereof
08/26/2014US8816071 Tocotrienol derivatives and associated methods
08/26/2014US8815888 Forms of rifaximin and uses thereof
08/26/2014US8815872 Macrocyclics pyrimidines as aurora kinase inhibitors
08/26/2014CA2604686C (1, 10b-dihydro-2-(aminoalkyl- phenyl)-5h-pyraz0l0 [1,5-c] [1,3] benz0xazin-5-yl) phenyl methanone derivatives as hiv viral repliation inhibitors
08/21/2014WO2014125444A1 Heterocyclic amides as kinase inhibitors
08/21/2014US20140235855 Tricyclic Antibiotics
08/21/2014US20140235662 Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect
08/21/2014US20140235654 Use of derivatives of indoles for the treatment of cancer
08/21/2014US20140235620 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
08/21/2014US20140235615 Heterocyclic compound
08/21/2014US20140234333 Compositions and methods for inhibition of the jak pathway
08/20/2014EP2766021A1 Compounds for the treatment of hepatitis c
08/19/2014US8809320 Benzodiazepine derivatives
08/19/2014US8809318 Gamma secretase modulators
08/19/2014US8808941 Naphthoxazine benzoxazine-based monomer, polymer thereof, electrode for fuel cell including the polymer, electrolyte membrane for fuel cell including the polymer, and fuel cell using the electrode
08/19/2014CA2762878C Crystalline forms of a pharmaceutical compound
08/14/2014WO2014123894A1 Macrocyclic compounds as hcv entry inhibitors
08/14/2014WO2014123892A1 Macrocyclic molecules as hcv entry inhibitors
08/14/2014WO2014122067A1 New indanyloxydihydrobenzofuranylacetic acids
08/14/2014WO2014121418A1 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
08/14/2014US20140228377 Methylpiperidine derivative
08/14/2014US20140228361 Aminoquinazoline derivatives and their salts and methods of use
08/14/2014US20140228353 Compounds and methods of treating diabetes
08/14/2014US20140228352 Heterocyclic compound
08/14/2014US20140228347 Compounds and compositions as c-kit kinase inhibitors
08/14/2014US20140228320 Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors
08/13/2014EP2764865A2 Cancer treatment
08/13/2014EP2763997A1 Cyclohexyl-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists
08/13/2014EP2763993A1 Heterocyclylpyri(mi)dinylpyrazole
08/13/2014EP2763987A1 Heterocyclylpyri (mi) dinylpyrazole as fungicidals
08/13/2014EP2763982A1 Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases.
08/13/2014EP2763979A1 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
08/13/2014CN103987717A 生育三烯酚衍生物以及相关的方法 Tocotrienol derivatives and related methods
08/13/2014CN103987707A 吡唑-4-基-杂环基-甲酰胺化合物以及使用方法 Pyrazol-4-yl - heterocyclyl - carboxamide compound, and use of
08/13/2014CN103987698A 作为激酶lrrk2调节剂用于治疗帕金森病的2-苯基氨基嘧啶衍生物 Amino-pyrimidine derivatives as kinase lrrk2 modifier used to treat Parkinson's disease 2-phenyl
08/13/2014CN103980291A 从辣木根部提取辣木素的方法 The method of extraction from Moringa Moringa root hormone
08/13/2014CN103980290A 具有杀虫活性的吗啉并环类化合物、及其制备和用途 Having insecticidal activity and morpholine ring compounds, their preparation and use
08/13/2014CN103980287A 含色酮腙结构的噻吩并嘧啶类化合物的制备及应用 Preparation and Application of thiophene color hydrazone structure containing pyrimidine compounds
08/13/2014CN102584852B 真菌代谢产物桥南霉素及其制备方法和应用 Fungal metabolites Bridge ADM and its preparation method and application
08/13/2014CN102050722B 4-联苯基取代的吡唑烷-3,5-二酮衍生物 4-biphenyl substituted pyrazole-3,5-dione derivative
08/13/2014CN102046603B 作为抗细菌剂的[4-(1-氨基-乙基)-环己基]-甲基-胺及[6-(1-氨基-乙基)-四氢-吡喃-3-基]-甲基-胺衍生物 As an anti-bacterial agent, [4- (1-amino - ethyl) - cyclohexyl] - methyl - amine and [6- (1-amino - ethyl) - tetrahydro - pyran-3-yl] - methyl base - amine derivatives
08/13/2014CN101273096B 生物分子用标记色素、标记试剂盒以及生物分子的检测方法 Biomolecules with a labeling dye and labeling kit biomolecules detection method
08/13/2014CN101175760B 雷帕霉素的39-去甲氧基衍生物 Rapamycin 39- to methoxy derivative
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 220